Feedback / Questions
BBO-8520 - BridgeBio Oncology Therapeutics
https://www.globenewswire.com/news-release/2026/09/08/3358113/0/en/bbot-announces-new-bbo-8520-data-highlights-strategic-focus-on-2l-nsclc-bbo-8520-combination-as-well-as-bbo-11818-and-bbo-10203-combinations-in-kras-mutant-cancers.html
Sep 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next